Aurinia Pharmaceuticals Inc Ordinary Shares Earnings Dividend

Aurinia Pharmaceuticals Inc Ordinary Shares’s revenue jumped 18.87% since last year same period to $83.22Mn in the Q2 2026. On a quarterly growth basis, Aurinia Pharmaceuticals Inc Ordinary Shares has generated 7.1% jump in its revenue since last 3-months.

Aurinia Pharmaceuticals Inc Ordinary Shares’s net profit jumped 73.91% since last year same period to $37.41Mn in the Q2 2026. On a quarterly growth basis, Aurinia Pharmaceuticals Inc Ordinary Shares has generated 8.9% jump in its net profits since last 3-months.

Aurinia Pharmaceuticals Inc Ordinary Shares’s net profit margin jumped 46.3% since last year same period to 44.96% in the Q2 2026. On a quarterly growth basis, Aurinia Pharmaceuticals Inc Ordinary Shares has generated 1.69% jump in its net profit margins since last 3-months.

Aurinia Pharmaceuticals Inc Ordinary Shares’s earning per share (EPS) estimates for the current quarter stand at 0.18 - a 12.5% jump from last quarter’s estimates.

Aurinia Pharmaceuticals Inc Ordinary Shares’s earning per share (EPS) estimates for the current year stand at 0.18.

Aurinia Pharmaceuticals Inc Ordinary Shares’s earning per share (EPS) jumped 75% since last year same period to 0.28 in the Q2 2026. This indicates that the Aurinia Pharmaceuticals Inc Ordinary Shares has generated 75% annual rate of jump in its earning per share (EPS) in the last 4 quarters.